镰状细胞贫血患者红细胞中α血红蛋白稳定蛋白浓度及羟基脲治疗的影响
本研究开发夹心ELISA法测定红细胞裂解液中α血红蛋白稳定蛋白(AHSP)浓度,比较对照组、未治疗及羟基脲治疗的镰状细胞贫血(SCA)患者。未治疗SS基因型患者AHSP浓度显著高于对照,羟基脲治疗后显著下降但仍高于对照,AHSP与α血红蛋白池强正相关。
要点
- AHSP浓度在未治疗SCA患者中显著升高,羟基脲治疗后下降。
- AHSP浓度与α血红蛋白池呈强正相关。
- AHSP或可作为监测SCA患者羟基脲反应的候选生物标志物。
核心结论
- AHSP浓度可作为监测SCA患者羟基脲反应的候选生物标志物,并提示AHSP在多种红细胞疾病中可能起作用。
研究设计与样本
- 研究纳入对照组10例、接受羟基脲治疗的SCA患者10例和未治疗SCA患者12例,测定红细胞裂解液中AHSP浓度。
主要发现
- 三组合并后AHSP浓度与α血红蛋白池呈强正相关。
临床怎么用
- AHSP浓度或可用于监测SCA患者对羟基脲的治疗反应。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Alpha haemoglobin-stabilising protein (AHSP) is a key chaperone synthesised in red blood cell (RBC) precursors. Many studies have reported AHSP as a potential biomarker of various diseases. AHSP gene expression has been studied in detail, but little is known about AHSP protein levels in RBCs. We investigated the AHSP concentration of RBC lysates from control subjects (n = 10) and patients with sickle cell anaemia (SCA) with (n = 10) and without (n = 12) hydroxycarbamide (HC) treatment, to evaluate the clinical relevance of AHSP in SCA. We developed a sandwich enzyme-linked immunosorbent assay method, with which we were able, for the first time, to determine the mean AHSP concentration in control RBC lysates (0·82 µg/ml). The AHSP concentration (2·23 µg/ml) was significantly higher in untreated patients with the SS genotype than in controls. The AHSP concentration decreased significantly on HC treatment (1·50 µg/ml) but remained significantly higher than that in controls. A strong positive correlation was observed between the AHSP concentration and the α-haemoglobin pool with the three groups of subjects pooled into a single group. Our present findings indicate that AHSP concentration can be considered a candidate biomarker for monitoring HC responses in patients with SCA and suggest a role for AHSP in various RBC diseases.
引用
- Vasseur C, Domingues-Hamdi E, Pakdaman S, et al. Alpha haemoglobin-stabilising protein concentration in the red blood cells of patients with sickle cell anaemia with and without hydroxycarbamide treatment. Br J Haematol. 2021. PMID: 34378186. doi:10.1111/bjh.17728
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。